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Introduction  29 
 30 
During the 20th century, a number of chemicals currently used in households, industries, agriculture, or 31 
in veterinary and human health were introduced into the environment, many of which are considered 32 
persistent. Among them, pharmaceuticals (Phs) are widely used drugs of which more than 4,000 33 
medical compounds are used today (Kümmerer, 2009). The fate and occurrence of these 34 
micropollutants in aquatic media is not yet fully understood. They do not need to be persistent to cause 35 
negative effects because their transformation or removal is compensated by their continuous 36 
introduction into media and by the synergistic effects of complex mixtures being released into the 37 
environment (Pomati et al., 2008). For the first time in the European Union, three pharmaceuticals will 38 
be included on a "watch list" of emerging pollutants (2011/0429, COD), which could one day be placed 39 
on the priority list. The new list acknowledges the risks posed by the three widely used 40 
pharmaceuticals: hormonal preparations 17-alphaethinylestradiol and 17-beta-estradiol, and painkiller 41 
diclofenac, which is suspected of killing fish. 42 
A vast amount of literature focusing on analytical aspects, removal processes, presence in aquatic 43 
media, laboratory experiments, review papers etc., is available (http://www.epa.gov/ppcp/lit.html). 44 
Most contributions address wastewater treatment (WWT) to remove these emerging pollutants in 45 
effluent water, but also treated wastewater (TWW) reuse is of growing concern. Among the potential 46 
uses of reclaimed water, aquifer recharge from treated urban wastewater (flooding, injection) is being 47 
increasingly used in areas where water is scarce in order to supplement water resources (Díaz-Cruz and 48 
Barceló, 2008) or to form a seawater intrusion barrier (Argo and Cline, 1985).  However, although 49 
some Phs are partially removed by conventional WWTs, they still may remain in the treated water and 50 
in the long term create undesirable effects in aquatic media affecting its final use (Ternes et al., 2002).  51 
The presence of Ph residues in groundwater has been intensively investigated mainly from effluent 52 
recharge ponds (Sacher et al., 2001), feedlots (Lindsey et al., 2001; Zhu et al., 2001; Hamscher et al., 53 
2002; Batt et al., 2006), waste control facilities (Andrews et al., 2012; Bartelt_Hunt et al., 2011) and 54 
riverbanks (Vogel et al., 2005; Banzhaf et al., 2013). In many cases where geohydrological information 55 
is available, antibiotic residues have been detected mainly in shallow phreatic aquifers at depths of 3-6 56 
m below the ground surface (Krapac et al., 2002; Batt et al., 2006). 57 
Much research has focused on the removal of compounds during infiltration through the unsaturated 58 
zone (Heberer et al., 2004; Massmann et al., 2006). However, few studies have traced results for 59 
recharged TWW directly incorporated into saturated media (groundwater), where attenuation processes 60 
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occurring in the unsaturated zone do not occur. The fate of organic contaminants depends on 61 
geochemical and nutrient conditions (Lapworth et al., 2012), and low dissolved oxygen/low nutrient 62 
conditions favour long-term persistence. A reducing environment has been seen as being important to 63 
control the fate and transport of some organic compounds with an otherwise high attenuation potential. 64 
While TWW is low in DOM (dissolved organic matter) and is fully oxygenated, DOC (dissolved 65 
organic carbon) in wells is low because deep groundwater tends to contain relatively low DOM 66 
concentrations (Kaplan and Newbold, 1993). In addition, factors such as porosity, permeability and 67 
groundwater velocity control the fate of contaminants. 68 
In previous research from Cabeza et al. (2012) the following pharmaceuticals were detected in the 69 
lower Llobregat delta aquifer (Barcelona, Spain) prior to the injection processes (baseline): 4-AA, 4-70 
MAA, codeine, ibuprofen, iopamidol, iopromide, ketorolac, loratadine, paraxanthine and pravastatin. 71 
This study attempts to evaluate whether, and to what extent, aquifer quality is affected by the presence 72 
of new pharmaceuticals due to artificial recharge from TWW during 2007-2010. Specifically, a 73 
screening survey for 81 pharmaceuticals (antibiotics, lipid-regulating agents, analgesic/anti-74 
inflammatory drugs) was conducted in the Llobregat area at different sampling sites. In this area, TWW 75 
was injected into aquifer media for seawater intrusion control purposes. The primary objectives of this 76 
study were to: (1) determine the distribution of a wide range of pharmaceuticals in the TWW and 77 
groundwater receiving these discharges; (2) assess the likelihood of migration through a sand-gravel 78 
aquifer using a combination of field observations and literature data; and (3) to investigate 79 
hydrochemical changes in aquifer media and pharmaceuticals presence. The secondary objective was to 80 
compare the distribution and likely behaviour of compounds in the subsurface environment with those 81 
observed in injected waters. 82 
 83 
Study area 84 
 85 
The study site, the Depurbaix wastewater facility, is located in the Llobregat river delta south-west of 86 
the city of Barcelona, NE Spain (see Figure 1). The Depurbaix Wastewater Treatment Plant treats 87 
urban wastewater from the southern part of Barcelona and its surroundings, where the population is one 88 
million. Before the tertiary treatment a pre-treatment for the elimination of settleable solids and grease, 89 
as well as nutrient removal by activated biological sludge was applied. Tertiary treatment consisted of 90 
flocculation-coagulation, lamellar clarification followed by filtration and UV disinfection. Before 91 
injection into the aquifer, the water received additional treatment: perchloration, ultrafiltration, reverse 92 
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osmosis and UV disinfection. A detailed description of the treatment plant facility is presented in 93 
Cazurra (2006). The volume of water to be reused at the Depurbaix facility is destined to meet various 94 
demands, and one of the objectives is the construction of a hydraulic barrier against sea water intrusion 95 
in the Llobregat delta deep aquifer. 96 
From the geological point of view, the Llobregat delta is a Quaternary age formation covering 97 97 
km2 of unconsolidated sediments of alluvial origin varying from clay to gravel, and it is deposited over 98 
blue clay dating back to the Pliocene age, except on the northern boundaries, which overlie older 99 
materials. In the delta area, two coastal detrital aquifers (upper and lower) from the quaternary age exist 100 
(Fig. 1) but exploitation of the upper aquifer has been abandoned due to the highly polluted water.  101 
Research into the lower aquifer has been driven by its value as a strategic water resource for supply, 102 
which is the principal objective of all the research conducted (Custodio, 1981). Over the years the 103 
intensive exploitation of the deep aquifer has led to the presence of seawater intrusion in different parts, 104 
which has recently been made worse by a number of civil work excavations of the impervious layer at 105 
the contact between the aquifer and the sea. As a result, groundwater quality has progressively 106 
deteriorated, and the possibilities of exploitation have been reduced. Annual surveys have been 107 
conducted since the 1960s, when seawater intrusion was first detected. 108 
In 2006, the first hydraulic barrier construction phase was initiated (Ortuño et al., 2008) over an area 109 
of above 2.5 km2 (Fig. 1). The hydraulic barrier scheme consists of injecting TWW, which forms a 110 
pressure ridge along the coast to prevent seawater from entering the aquifer. The TWW for the 111 
hydraulic barrier consists of the outflow water from the Depurbaix sewage treatment plant, which 112 
undergoes the previously described treatment before being stored in a tank for further injection in the 113 
lower aquifer through wells.  114 
In the facility, four injection wells (P1 to P4) were constructed prior to the water injection up to a 115 
depth of 70 m, and were screened throughout the lower aquifer thickness (59-65 m below the soil 116 
surface). The wells are located 1,500 m inland and stand in a line that runs in parallel to the coastline, 117 
with a 300-m distance separating each one (Fig. 1). In March 2007, water injection started in P3 and 118 
P4, and in P2 in July 2007. Well P4 had to be discarded almost immediately due to technical problems. 119 
In July 2008, P1 started functioning. Only wells P1, P2 and P3 were undergoing recharge operations 120 
during this first phase. In April 2010, the second barrier phase commenced with 14 injection wells. 121 
During the first phase, the initial injection (620 m3day-1) consisted of an equal mixture of TWW and 122 
tap water from the storage tank. In March 2008, the fraction of tap water was removed and well 123 
injection was carried out only with reclaimed water, when the daily volume increased to 2,500 m3day-1. 124 
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Altogether, the system was operating during the monitored period (2007-2010), except for April 26 to 125 
July 21 (2008), when the system was out of order due to technical reasons.  126 
 127 
The delta aquifers. The lower aquifer 128 
 129 
From the hydrogeological point of view, two aquifers are distinguished in the Llobregat delta, the 130 
upper unconfined and the deep or lower aquifer, which are separated by a low permeability silt wedge 131 
confining the lower, except on the borders of the delta where the silt package pinch out, and the upper 132 
and lower aquifers are connected by fine sand layers. Both aquifers are hydraulically connected only on 133 
the borders of delta area. In some specific areas however, damaged wells (e.g. corrosion or failure of 134 
well casing or screen, improper design or construction) interconnecting the upper and lower aquifers 135 
may also exist. The main source of natural recharge comes from the Llobregat river infiltration, mainly 136 
in the upper valley, jointly with irrigation water returns to the upper aquifer; discharge is performed 137 
through pumping wells and to the sea. The estimated transit time from the river valley recharge to the 138 
study area is 10 years (Custodio, 1981). 139 
The aquifer of interest where artificial recharge takes place, the lower one confined by the silt layer, 140 
is composed by fine sand and gravel, with an average thickness of 6 m. It almost occupies the entire 141 
delta surface, extending under the sea below the silt wedge. The top aquifer depth is generally more 142 
than 50 m below the surface soil, and the deepest part of the aquifer’s upper limit is 60 m below sea 143 
level. The aquifer’s hydraulic properties are characterised by significant lateral changes due to the 144 
heterogeneity of the lithological facies and the presence of paleochannels; transmissivity values from 145 
100 to 31,000 m2 day-1 have been reported (Iríbar et al., 1997). The transmissivity values from the 146 
pumping tests done within the frame of this hydraulic barrier project are 700 and 2,000 m2day-1, 147 
respectively, for the vicinity of wells P1 and P3, whereas for P2 and P4 is 100 and 200 m2day-1, 148 
respectively.  149 
The deep aquifer has been intensively exploited for industrial and water supply, which has led to the 150 
lowering piezometric levels. By 1977, the groundwater drawdown reached a maximum of 30 m b.s.l in 151 
the centre-right corner of the area; as a result of seawater intrusion maximum chloride concentration in 152 
wells was 20,000 mgl-1 at the north-eastern part of the aquifer. Before the 1960s the aquifer water type 153 
was originally of calcium-bicarbonate composition. At present, the sodium-chloride facies is 154 
predominant on approximately two thirds of the aquifer area; piezometric levels in most of the area are 155 
below sea level. Since the 1960s, the hydrogeological aspects of the seawater intrusion wedge have 156 
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been extensively studied, reflected by a number of reports and publications (Candela et al, 1988; Iríbar 157 
et al., 1997, among others).  158 
At the end of the first hydraulic barrier phase (March 2010), the total volume injected into the 159 
aquifer accounted for 1.6 Mm3, leading to quantitative and qualitative changes to groundwater. An 160 
average increase in groundwater of 1 m level was observed in the monitored wells (June 2010), being 161 
up to 4 m for wells located in the western part of the barrier, favoured by the highest transmissivity of 162 
the aquifer. Regarding water quality, the average Cl- content in sampled wells had been reduced to 350 163 
mgl-1, similar to aquifer values found in not affected areas by seawater intrusion; Electrical 164 
Conductivity (EC) and pH was around 1,500 Scm-1 and 7.4, respectively. As the aquifer is saturated 165 
with the saltwater entering porous media, its cationic composition is expected to be altered by chemical 166 
reactions. It is worth to mention that although TWW was oversaturated with calcite, which could 167 
implies the possibility of carbonate precipitation in mixing waters, well-clogging problems were not 168 
observed. 169 
 170 
Materials and methods 171 
 172 
Selected pharmaceuticals 173 
 174 
The CAS number and use of the 81 selected compounds for monitoring are presented in Table. 175 
Basically, their choice was based on the metabolism routes of pharmaceuticals 176 
(http://chem.sis.nlm.nih.gov/chemidplus; Lapworth et al., 2012), chemical analysis availability, 177 
literature results from previous studies and their ample use. In addition, persistence in aquatic media 178 
(i.e., carbamazepine, Gielen, 2007; Banzhaf et al., 2013) and environmental risk were considered (i.e., 179 
endocrine disruptors, PAHs; http://ec.europa.eu/research/endocrine/background_disruption_en.html).  180 
 181 
Sampling 182 
 183 
Sampling the sites for pharmaceuticals consisted of bi-monthly groundwater sample collection from the 184 
monitoring network of the Agencia Catalana del Aigua (ACA), and also in injected water into wells P1 185 
to P3. The location of the monitoring and injection wells is shown in Figure 1. The sampling period and 186 
groundwater level monitoring covered the March 2007-May 2010 period.  187 
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The local groundwater monitoring network for the Llobregat deep aquifer consisted of five wells 188 
(RL1 to RL5) and two piezometers (Mp47 and B7-b), located at a distances between 250 m and 800 m 189 
to the four injection wells (P1- P4), except Mp47, which was located 4 m from P1. Network monitoring 190 
included an initial sampling campaign for the aquifer receiving recharge prior to the TWW injection 191 
(March, 2007). All the samples were collected using one litre Teflon-coated amber glass bottles, which 192 
were immediately stored in an insulated container chilled with ice packs for shipment to the 193 
laboratories. The transit time for sample shipment was less than 24 h.  194 
Monthly water samples were collected in 500 ml glass bottles in order to analyse major ions, 195 
physico-chemical parameters (pH, temperature, EC, total dissolved solids (TDS) and total organic 196 
carbon content (TOC). 197 
 198 
Pharmaceuticals and standard water chemical analyses 199 
 200 
The methods used for the pharmaceuticals analyses were based on liquid chromatography-Q-TRAP-201 
Mass Spectrometry.  Column: C-18 (3x250 mm, 5μm particle size). Interface polarity: ESI (+) and ESI 202 
(-). Mobile phase: ESI (+), water (formic acid 0.1%)/ACN ESI (-), water (0.05% ammonium 203 
formate)/CAN and Operation mode: MRM. For detailed information on sample pre-treatment, 204 
extraction technique and analytical methods applied, readers are referred to Robles-Molina et al. 205 
(2014). All the chemical determinations were conducted at the Department of Physical and Analytical 206 
Chemistry laboratory, University of Jaen (Spain). 207 
The regulated chemicals, major ion content and physical characteristics of the TWW and 208 
groundwater samples were controlled by the ACA, following standard laboratory methods. The in situ 209 
analysis included pH, EC, redox potential (Eh), dissolved oxygen and temperature. These 210 
determinations were made using an in-situ probe Eijelkamp® 18.28.  211 
 212 
Aquifer geologic material characterisation 213 
 214 
The geologic material from the lower aquifer (at 59-61 and 63-65 m below the soil surface) was 215 
collected from three undisturbed soil cores obtained from three wells. Samples were stored in 216 
polyethylene bags for transportation and were air-dried prior to any characterisation and testing done in 217 
the laboratory. Core samples were thoroughly mixed for the parameters determination. 218 
 To characterise porous media, the soil parameters that follow were obtained in the laboratory using 219 
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ASTM (1993) standards: bulk density (d), porosity, grain size distribution, organic matter content, and 220 
electric conductivity (Scm-1) at the 1:5 ratio. Soil pH was determined in deionised water at a soil 221 
solution ratio of 1:5; for organic matter content, the Walkley and Black method was applied. Cation 222 
exchange capacity (CEC; mmolc kg
-1 of solid) and exchangeable cations were measured using the 223 
ammonium/sodium acetate method and the ammonium acetate method, respectively. Mineral content 224 
and type of clays were obtained through X-ray diffraction, XRD, from three samples. A Bruker D-5005 225 
X-ray diffractometer was employed with a Cu target tube, and was operated at 40 kV and 30 mA. The 226 
EVA software package (Bruker AXS, Germany) and the PDF2 database (ICDD, Denver, USA) were 227 
employed for mineral phase identification. 228 
 229 
Results and discussion 230 
 231 
Aquifer soil-matrix characteristics 232 
 233 
Average sediment texture consists of a fairly graded sandy sediment (around 50%) with a strong 234 
calcareous composition and a low clay content, with clinochlore and illite being the minerals that 235 
dominate the clay fraction; presence of iron or manganese was not detected in the sediment material. 236 
Organic carbon was always lower than 0.6 wt%, pH was 8.5 and EC was 272 Scm-1 at 25ºC. The 237 
CEC value was 22.5 mmolc kg-1. Given the aquifer material characteristics, sorption reactions were 238 
not expected to be the most important process controlling the fate of the studied compounds (Teijón et 239 
al., 2013). Porosity was 0.20 and bulk density was 2.1 g cm-3. 240 
 241 
TWW and groundwater major ions characteristics 242 
 243 
At the end of the studied period, TWW and groundwater mixture was between 75% and 25% for those 244 
wells located in the vicinity of the injection wells characterised by the highest aquifer transmissivity 245 
values. The effect of TWW recharge in the aquifer was assessed by monitoring the EC, +Eh and 246 
oxidised species changes in wells. Selected parameters are indicators of the groundwater 247 
hydrochemical state and they are easily measurable. During the 2007-2010 period, the TWW was 248 
characterised by presence of oxidised species, positive Eh values and average EC was 2,000 Scm-1. 249 
In figure 2 concentration of Cl-, SO4
= and HCO3
- in the aquifer media (RL1, RL2 and RL5 wells) 250 
with time has been plotted, showing the decrease of measured values in all monitored wells and 251 
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monitored period. For well RL5 a marked decrease trend of Cl- is observed although HCO3
-
 252 
concentration remains between 210 and 250 mgl-1. This fact maybe related to aquifer carbonate matrix 253 
dissolution, as assessed by the calcite saturation index of groundwater, SIcal. At the initial state of 254 
TWW injection groundwater was oversaturated, whereas at the end of the studied period pH increased 255 
and water became undersaturated on calcite (SIcal down to -0.2). Nevertheless, HCO3
- generation by the 256 
CH4 oxidation to CO2 should not be overestimated. After the studied period the sodium-chloride 257 
aquifer water type evolved to a bicarbonate-sulphate facies, as shown by the Stiff diagrams (Fig. 3). 258 
 259 
Pharmaceutically active compounds found in TWW and groundwater 260 
 261 
The analysis of Phs presence was based on the results obtained from the wells RL1, RL2, RL3 and 262 
RL5. Data from piezometer B-7b were considered inaccurate and were consequently eliminated; its 263 
spatial location in the aquifer media might explain this fact. The records available for MP47, located 4 264 
m from well P1, extended only to May 2009 (injection started in April 2008) and they were not 265 
considered for further analysis considering the short monitored period. However, based on a visual data 266 
inspection (not shown here), the effects of injection were immediately reflected in the groundwater 267 
composition due to the small distance between the well and the piezometer.  268 
It was considered that the EC decrease in groundwater samples was not only an indicator of the 269 
injected water breakthrough in the monitoring wells, but also a good travel time estimation to the wells. 270 
Also, presence of the persistent anticonvulsant carbamazepine in the wells was considered an indicator 271 
of the injected water front. Carbamazepine undergoes low degradation/biodegradation, and little or no 272 
sorption takes place in water sediment systems due to a limited interaction with the negatively charged 273 
mineral surfaces in aquifer materials, irrespectively of the redox state (Gielen, 2007, Bertelkamp et al., 274 
2012). The baseline concentration of carbamazepine was found to be below the detection limit (Cabeza 275 
et al., 2012). The travel time to the RL1, RL2 and RL5 wells was estimated to be approximately 1 year, 276 
while for RL3, located around 200 m south of RL1, injected water was detected around 2 years later of 277 
initial injection. The geometry and heterogeneity of the delta aquifer, the paleochannels spatial 278 
distribution and the lowest transmissivity on P2 well (100 m2day-1) may explain the observed 279 
differences in travel times. 280 
As presented in Table 1, among the selected pharmaceuticals, 62 active compounds were found at 281 
least in one sample water at concentrations ranging between detection and quantification limits (ngl-1). 282 
Some pharmaceuticals were not eliminated after the wastewater treatment and were still at detectable 283 
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concentration levels. Ten compounds  (4-AA, 4-MAA, codeine, ibuprofen, iopamidol, iopromide, 284 
ketorolac, loratadine, paraxanthine and pravastatin, Tables 1, 2) were removed after the tertiary and 285 
additional treatment of influent water being detected only in groundwater samples. 286 
Four targeted compounds (acetaminophen/paracetamol-analgesic, amitriptyline-antidepressant, 287 
azithromycin-antibiotic, ranitidine-histamine H2-receptor drug; see Table 1) were occasionally detected 288 
at low concentration values in TWW samples. Seasonality of detected compounds in the TWW was not 289 
observed. The increase in compounds concentration at some time periods may be associated with either 290 
their greater consumption or the possible failures linked to the treatment plant. Decrease of 291 
concentration during treatment was not targeted as we were interested primarily in the subsurface 292 
behaviour of compounds due to injection. 293 
Table 2 presents all the pharmaceuticals found at detectable concentration (>0.1gl-1, threshold 294 
concentration selected for analysis of results) in the TWW being injected and groundwater samples 295 
during the study period. Minimum, maximum and average concentration is also calculated. Discarding 296 
Phs only detected in groundwater: caffeine, ciprofloxacin, diclofenac, erythromycin, gemfibrozil, 4-297 
AAA, naproxen, 4-FAA and ofloxacin present the maximum concentration values, greater than 400 298 
ngl-1 in both type of waters.  299 
Although during the study period obtained results show that 20 new Phs were not eliminated during 300 
the treatment in the plant, being introduced through the injection wells in aquifer media, only eleven 301 
compounds were detected in both the TWW and in monitoring wells. These were:  carbamazepine, 302 
ciprofloxacin, diazepam, diclofenac, hydroclorothiazide, mepivacaine, 4-AAA, 4-FAA, 303 
sulfamethoxazole, sulfamethazine and sulfapyridine. In RL1 well ciprofloxacin instead of 304 
sulfamethoxazole was detected. The eleven pharmaceuticals have different functional groups and 305 
acid/basic properties, and belong to the antibiotics, nonsteroidal anti-inflammatory drugs-NSAIDs, 306 
anxiolytic and diuretics groups of action. Loos et al. (2010) also reported a frequency of detection of 307 
42% and 24% for carbamazepine and sulfamethoxazole, in European groundwater. 308 
Compounds in RL5 and RL2 wells displayed similar breakthrough (with small retardation for RL2) 309 
and range of concentration values, being much lower in RL1 (Fig. 4). For RL3, due to longer travel 310 
time of injected water, compounds were detected since May 2008 and only 1-year of monitoring period 311 
was available. The most persistent pharmaceuticals detected in wells were: 4-AAA, carbamazepine, 4-312 
FAA and hydroclorothiazide. For all of them, concentrations were significantly lower than TWW but 313 
greater than 100 ngl-1. 314 
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Carbamazepine, a widely used pharmaceutical of the amide group, was detected in all the 315 
monitoring wells, with a maximum concentration of 134 ngl-1 in RL5 being of 169 ngl-1 in injected 316 
TWW. It is one of the most frequently detected compounds in groundwater and is highly persistent 317 
given the nature of the molecule (neutral and resistance to hydrolysis), as laboratory and field 318 
experiments have stated (Drewes et al., 2003; Chefetz et al., 2008); its presence in groundwater has 319 
reported by a number of researchers (Sacher et al., 2001; Rabiet et al., 2006; Loos et al., 2010; Fram 320 
and Belitz, 2011, among others). High concentrations of 4-AAA and 4-FAA (metabolites of metamizol, 321 
a phenazone-type compound) have been also found by Massmann et al. (2006) in mixed pond water 322 
with TWW effluents.  323 
Sulphonamides (sulfamethoxazole, sulfamethazine and sulfapyridine, weakly acidic compounds 324 
with pKa 5-8) were always detected in monitored wells at lower concentrations in this study (Fig. 3, 325 
Table 2). They are widely used antibiotics in humans, and especially in veterinary medicine, as an 326 
antimicrobial substance in intensive livestock production to prevent and treat diseases. They have 327 
amphoteric properties, offer poor chelating ability and a low soil sorption tendency. Residues of 328 
sulphonamides have been detected in the groundwater located in the proximity of a confined animal-329 
feeding operation (García-Galan et al., 2010). Sulfamethoxazole, also present in groundwater, is highly 330 
resistant to further biodegradation on the subsurface (Lam et al., 2004) and, consequently, it is 331 
minimally attenuated (Avisar et al., 2009; Fram and Belitz, 2011), mobile in saturated porous media 332 
presenting little influence to pH changes, ionic strength of solution and contradictory behaviour has 333 
been observed under different redox conditions (Chen et al., 2011; Banzhaf et al., 2012). It has a low 334 
Kow (−0.1 to 1.7; Primor, 2008), is considerably hydrophilic and is also polar. Such properties enable 335 
sulfamethoxazole to be transported over long distances without being adsorbed to sediments (Lindsey 336 
et al., 2001; Perez et al., 2005). Furthermore under typical environmental pH conditions (pH ~7-8), it is 337 
negatively charged (95-100%; Primor, 2008) a property that can augment its transport velocity in 338 
porous media due to anion exclusion. 339 
An attempt has been made to assess hydrochemical changes in the aquifer media taking into account 340 
Phs detection in RL1, RL2 and RL5 monitoring wells. In figure 4 groundwater and TWW 341 
concentration of some major and redox sensitive components (NO3
-, O2 and NH4
+), carbamazepine, 342 
hydrochlorothiazide, 4-AAA, 4-FAA, sulphonamides and diclofenac have been plotted over time.  Also 343 
as removal of many substances is redox-dependent, the time redox front and Cl- concentration as 344 
indicator of the saline front movement breakthrough, have been plotted. Redox front was defined 345 
considering all sensitive components to redox changes in water (Chapelle, 2001). 346 
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Both hydrochemical processes, change from anoxic to oxic redox conditions and decrease of Cl- 347 
concentration in the monitored wells due to dilution with the injected oxic TWW, took place at 348 
approximately 1 year after start of injection (2008). At the beginning of the injection period (2007), the 349 
NH4
+ (reduced species) was present in saline water of wells at concentration close to 2 mgl-1 (RL1 and 350 
RL2) and greater than 15 mgl-1 (RL5); presence of oxidised species (e.g., NO3
- and O2) as a result of 351 
the TWW oxidation front was clearly observed after 2008 (Fig. 4). The increase of dissolved oxygen 352 
(up to 10 mgl-1) was introduced by the injected TWW whereas nitrate was also produced by injected 353 
TWW but with an added surplus of ammonia oxidation. The groundwater oxic conditions appeared to 354 
be initially detected for wells RL2 and RL5 in June-July, and later (October) for RL1. The observed 355 
decrease of Phs concentration, appears to be more associate with the dilution process in the aquifer 356 
media than other transformation or degradation processes, fact also reported by other researchers (Laws 357 
et al., 2011). 358 
For the Phs only found in groundwater (Table 1), they are very common, non-prescription/regulated 359 
compounds (e.g. paranxanthine a metabolite of caffeine, or contrast agents). Their presence maybe 360 
related to their high excretion as unchanged drug (codeine), high consumption rate (paranxanthine) or 361 
persistence (organic iodine) and apparently although further research is needed, they are not affected by 362 
changing redox. They are believed to have been released in the aquifer recharge area before the TWW 363 
injection, and residues are still present in the aquifer system (according to Teijón et al., 2010 tracing 364 
groundwater recharge revealed absence of Tritium). Different mechanisms and sources may explain 365 
presence of Phs in groundwater, ranging from disposal of treated effluents (and sludge) to the land or to 366 
surface streams hydraulically connected to aquifers, as may happen in the Llobregat valley; the 367 
possible leakage from sanitary sewer infrastructure in the boundary delta areas where only one aquifer 368 
exists, or, are thought to be the result of damaged wells connecting surface and deep aquifer. Illegal 369 
dumping in abandoned wells cannot be also discarded.  370 
 371 
Conclusions 372 
 373 
Artificial recharge, including injection through wells, can be generally considered a technique used in 374 
many parts of the world to enable the efficient use of non-conventional water resources that are 375 
currently not captured. However, it may also serve to transport pollutants into groundwater, especially 376 
highly polar molecules; occurrence may diminish with aquifer depth and distance from the injection 377 
wells. Although hydro-dispersive and reactive processes may diminish the original concentration of 378 
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Phs, aquifers may supply water containing these compounds and their metabolites for long periods 379 
(years-decades) as a consequence of low groundwater velocities, sluggish microbial activity and redox 380 
conditions. 381 
At the study site, injected TWW significantly decreased Cl- concentration in all monitored wells, 382 
showing a wider or narrower dilution range depending on the groundwater hydrochemical processes 383 
taking place and the hydraulic characteristics of the media. Redox process evolution in aquifer media 384 
by the mixing with injected TWW, led to changes from reduced species to oxidised species in 385 
groundwater following the oxidation front.  386 
It was found that a full characterization and quantification of Phs in aquifer media is difficult and 387 
challenging due to the continuous injection of TWW, variability of compounds pattern consumption 388 
along time and entrance pathways into groundwater systems. Transformation products where not 389 
analysed within this study, however, their possible presence may be relevant when the parent 390 
compound presence is not observed in any evaluate sample. The newly detected pharmaceuticals are 391 
generally polar compounds with weak acid/basic characteristics, with behaviour influenced by its 392 
dissociation in water. Compounds fell within the concentration range of ngl-1 and the results indicate 393 
that some may remain detectable in the wells located at a distance of around 1 km from the injection 394 
locations. The different concentration values found in the monitoring wells appear to be driven by 395 
distance from recharge wells, dilution processes in the aquifer media and to the hydraulic parameters 396 
that govern flow, with attenuation or degradation being much less important due to prevailing 397 
subsurface hydrochemical conditions.  398 
Although fate of Phs are determined by aquifer chemical and biological conditions and results from 399 
one system may not apply to other systems, obtained results may give important information for water 400 
resources management on fate of persistent compounds in subsurface media (Malamis et al. 2015). 401 
 402 
Acknowledgements 403 
This work has been carried out within the framework of Projects CONSOLIDER-TRAGUA and 404 
CGL2013-48802-C3-3-R, financed by the Spanish Ministry of Science and Innovation. We are grateful 405 
to Dr. Boluda for his technical support on aquifer material characterisation. We also acknowledge ACA 406 
and CUADELL for their help in the study development. This work is a contribution to the Group of 407 
Hydrogeology (RNM-308) of the Junta de Andalucía. The authors express their gratitude to the 408 
anonymous reviewer for their constructive comments to the revised manuscript which improved the 409 
quality of the paper  410 
411 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
References 412 
 413 
Andrews, W.J., Masoner, J.R., Cozzarelli, I.M., 2012. Emerging Contaminants at a Closed and an 414 
Operating Landfill in Oklahoma. Ground Water Monitor. Remed. 32(1),120-130. 415 
http://dx.doi.org/10.1111/j.1745-6592.2011.01373.x 416 
 417 
Argo, D.G., Cline, N.M., 1985. Groundwater Recharge Operations at Water Factory 21, Orange 418 
County, California. In Artificial Recharge of Groundwater, T. Asano ed. Boston, Mass., 419 
Butterworth. 420 
 421 
ASTM (American Society for Testing and Materials), 1993. Annual Book of ASTM Standards. 422 
American Society for Testing and Materials, West Conshohocken. PA. 423 
 424 
Avisar, D., Lester, Y., Ronen, D., 2009. Sulfamethoxazole contamination of a deep phreatic aquifer. 425 
Sci. Total Environ. 407(14), 4278-4282. http://dx.doi.org/10.1016/j.scitotenv.2009.03.032 426 
 427 
Bartelt-Hunt, S., Snow, D. D., Damon-Powell, T., Miesbach, D., 2011. Occurrence of steroid hormones 428 
and antibiotics in shallow groundwater impacted by livestock waste control facilities J. Contam. 429 
Hydrol. 123, 94-103. http://dx.doi.org/10.1016/j.jconhyd.2010.12.010. 430 
 431 
Banzhaf, S., Nödler, K., Licha, T., Krein, A., Sheytt, T., 2012. Redox sensitivity and mobility of 432 
pharmaceutical compounds in a low flow column experiment. Sci. Total Environ. 438, 113-121. 433 
http://dx.doi.org/ 10.1016/j.scitotenv.2012.08.041. 434 
 435 
Banzhaf, S., Krein, A., Sheytt, T., 2013. Using selected pharmaceutical compounds as indicators for 436 
surface and groundwater interactions in the hyporheic zone of a low permeability riverbank. 437 
Hydrol. Process. 27, 2892-2902. http://dx.doi.org/ 10.1002/hyp.9435. 438 
 439 
Batt, A.L., Snow, D.D., Aga, D.S., 2006. Occurrence of sulfonamide antimicrobials in private water 440 
wells in Washington County, Idaho, USA. Chemosphere, 64, 1963-1971. http://dx.doi.org/ 441 
10.1016/j.chemosphere.2006.01.029. 442 
 443 
Bertelkamp, C., Reungoat, J., Botton, S., Cornelissen, E., Ghadiri, E., de Jonge, M., Singhal, N., Van 444 
der Hoek, J.P., Verliefde, R.D., 2012. Transformation of organic pollutants during river bank 445 
infiltration: laboratory versus field data. Water practice & Technology 7(4). 446 
http://dx.doi.org/10.2166/wpt.2012.081. 447 
 448 
Cabeza, Y., Candela, L., Ronen, D., Teijón, G., 2012. Monitoring the occurrence of emerging 449 
contaminants in treated wastewater and groundwater between 2008 and 2010. The Baix Llobregat 450 
(Barcelona, Spain). J. Hazard. Mater. 239/240, 32-39. 451 
http://dx.doi.org/10.1016/j.jhazmat.2012.07.032. 452 
 453 
Candela, L., Olea, R., Custodio, E., 1988. Lognormal kriging for the assessment of reliability in 454 
groundwater quality control observation networks. J. Hydrol. 103, 67-84.        455 
http://dx.doi.org/10.1016/0022-1694(88)90006-6. 456 
 457 
Cazurra, T., 2006. Water reuse of south Barcelona's wastewater reclamation plant. Desalination. 218, 458 
43-51. http://dx.doi.org/10.1016/j.desal.2006.12.019. 459 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
 
 460 
Chapelle, F.H., 2001. Groundwater Microbiology and Geochemistry, 2nd edition. John Wiley & Sons, 461 
New York. 477 pp. 462 
 463 
Chefetz, B., Mualem, T., Ben-Ari, J., 2008. Sorption and mobility of pharmaceutical compounds in soil 464 
irrigated with reclaimed wastewater. Chemosphere. 73, 1335-1343.        465 
http://dx.doi.org/10.1016/j.chemosphere.2008.06.070. 466 
 467 
Chen, H., Gao, B., Li, H., Ma, L.Q., 2011. Effects of pH and Ionic Strength on Sulfamethoxazole and 468 
Ciprofloxacin Transport in Saturated Porous Media. J. Contam. Hydrol. 126, 29-36.        469 
http://dx.doi.org/10.1016/j.jconhyd.2011.06.002. 470 
 471 
Custodio, E., 1981. Sea water encroachment in the Llobregat and Besos areas near Barcelona 472 
(Catalonia, Spain). Intruded and relict groundwater of marine origin, 27. Proceedings of 7th 473 
SWIM, Uppsala. Sweriges Geologiska Undersokning, Rappoter och Meddelanden, Uppsala, p. 474 
120–52. 475 
 476 
Díaz-Cruz, M.S., Barcelo, D., 2008. Trace organic chemicals contamination in ground water recharge. 477 
Chemosphere. 72, 333-342. http://dx.doi.org/10.1016/j.chemosphere.2008.02.031. 478 
 479 
Drewes, J.E., Heberer, T., Rauch, T., Redderser, K., 2003. Fate of pharmaceuticals during groundwater 480 
recharge. Ground Water Monitor. Remed. 23(3), 64-72. http://dx.doi.org/10.1111/j.1745-481 
6592.2003.tb00684.x. 482 
 483 
Fram, M., Belitz, K., 2011. Ocurrence and concentrations of pharmaceutical compounds in 484 
groundwater used for drinking-water supply in California. Sci. Total Environ. 409, 3409-3417.        485 
http://dx.doi.org/10.1016/j.scitotenv.2011.05.053. 486 
 487 
García-Galán, M., Garrido, T., Fraile, J., Ginebreda, A., Díaz-Cruz, S., Barceló, D., 2010. 488 
Simultaneous coccurrence of nitrates and sulfonamide antibiotics in two groundwate bodies of 489 
Catalonia Spain. J. Hydrol. 383, 93-101. http://dx.doi.org/10.1016/j.jhydrol.2009.06.042. 490 
 491 
Gielen, G.J.H.P., 2007. The fate and effects of sewage-derived pharmaceuticals in soil. Ph.D. 492 
Dissertation. University of Canterbury, 173 pp. 493 
 494 
Hamscher, G., Sczesny, S., Höper, H., Nau, H., 2002. Determination of persistent tetracycline residues 495 
in soil fertilized with liquid manure by high-performance liquid chromatography with 496 
electrospray ionization tandem mass spectrometry. Anal. Chem. 74, 1509-1518. 497 
http://dx.doi.org/10.1021/ac015588m. 498 
 499 
Heberer, T., Mechlinski, A., Franck, B., Knappe, A., Massman, G., Pekdeger, A., Fritz, B., 2004. Field 500 
studies on the fate and transport of pharmaceutical residues in bank infiltration. Ground Water 501 
Monitor. Remed. 24, 70-77. http://dx.doi.org/ 10.1111/j.1745-6592.2004.tb00714.x. 502 
 503 
Iríbar, V., Carrera, J., Custodio, E., Medina, A., 1997. Inverse modeling of seawater intrusion in the 504 
Llobregat delta deep aquifer. J. Hydrol. 198, 226-244. http://dx.doi.org/10.1016/S0022-505 
1694(96)03290-8. 506 
 507 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
16 
 
Kaplan, L.A., Newbold, J.D., 1993. Biogeochemistry of dissolved organic carbon entering streams, in: 508 
Ford, T.E. (Ed.), Aquatic Microbiology: An ecological approach. Blackwell, Malden, 509 
Massachusetts, pp. 139-165. 510 
 511 
Krapac, I.G., Dey, W.S., Roy, W.R., Smyth, C.A., Storment, E., Sargent, S.L., Steele, J.D., 2002. 512 
Impacts of swine manure pits on groundwater quality. Environ. Pollut. 120, 475-492.        513 
http://dx.doi.org/10.1016/S0269-7491(02)00115-X. 514 
 515 
Kümmerer, K., 2009. The presence of pharmaceuticals in the environment due to humanuse – present 516 
knowledge and future challenges. J. Environ. Manage. 90. 2354-2366.        517 
http://dx.doi.org/10.1016/j.jenvman.2009.01.023. 518 
 519 
Lam, M.W., Young, C.J., Brain, R.A., Johnson, D.J., Hanson, M.A., Wilson, C.J., Richards, S.M., 520 
Solomon, K.R., Mabury, S.A., 2004. Aquatic persistence of eight pharmaceuticals in a 521 
microcosm study. Environ. Toxicol. Chem. 23, 1431-1440. http://dx.doi.org/10.1897/03-421. 522 
 523 
Lapworth, D.J., Baran, N., Stuart, M.E., Ward, R.S., 2012. Emerging organic contaminants in 524 
groundwater: A review of sources, fate and occurrence. Environ. Pollut. 163, 287-303. 525 
http://dx.doi.org/10.1016/j.envpol.2011.12.034. 526 
 527 
Laws, B.V., Dickenson, E.R.V., Johnson, T.A., Snyder, S.A., Drewes, J.E., 2011. Attenuation of 528 
contaminants of emerging concern during surface-spreading aquifer recharge. Sci. Total Environ. 529 
409, 1087-1094. http://dx.doi.org/10.1016/j.scitotenv.2010.11.021. 530 
 531 
Lindsey, M.E., Meyer, M., Thurman, E.M., 2001. Analysis of trace levels of sulfonamide and 532 
tetracycline antimicrobials in groundwater and surface water using solid-phase extraction and 533 
liquid chromatography/mass spectrometry. Anal. Chem. 73, 4640-4646. http://dx.doi.org/ 534 
10.1021/ac010514w. 535 
 536 
Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., Balsaa, P., Gans, O., Weiss, 537 
S., Blaha, L., Bolchi, M., Manfred, Gawlik, B., 2010. Pan-european survey on the occurrence of 538 
selected polar organic persistent pollutants in groundwater. Water Res. 44, 4115-4126.        539 
http://dx.doi.org/10.1016/j.watres.2010.05.032. 540 
Malamis, S., Andreadakis, A., Mamais D., Noutsopoulos, C., 2015. Can strict water reuse standards be 541 
the drive for the wider implementation of MBR technology?. Desal. and Water Treat. 53, 3303-542 
3308. http://dx.doi.org/10.1080/19443994.2014.933613 543 
 544 
Massmann, G., Greskowiak, J., Dunnbier, U., Zuehlke, S., Knappe, A., Pekdeger, A., 2006. The impact 545 
of variable temperatures on the redox conditions and the behavior of pharmaceuticals residues 546 
during artificial recharge. J. Hydrol. 328, 141-156.        547 
http://dx.doi.org/10.1016/j.jhydrol.2005.12.009. 548 
 549 
Ortuño, F., Niñerola, J.M., Teijón, G., Candela, L., 2008. Desarrollo de la primera fase de la barrera 550 
hidráulica contra la intrusión marina en el acuífero principal del Delta del Llobregat. Hidrogeol 551 
Recur Hidrául. Vol. XXVIII, 503–509. 552 
 553 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
17 
 
Perez, S., Eichhorn, P., Aga, D.S., 2005. Evaluating the biodegradability of sulfamethazine, 554 
sulfamethoxazole, sulfathiazole and trimethoprim at different stages of sewage treatment. 555 
Environ. Toxicol. Chem. 24, 1361-1367. http://dx.doi.org/ 10.1897/04-211R.1. 556 
 557 
Pomati, F., Orlandi, C., Clerici, M., Luciani, F., Zuccato, E., 2008. Effects and interactions in an 558 
environmentally relevant mixture of pharmaceuticals. Toxicol. Sci. 102, 129-137. 559 
http://dx.doi.org/ 10.1093/toxsci/kfm291. 560 
 561 
Primor, O., 2008. Sorption of antibiotic to clay. Master thesis, Tel Aviv University. 562 
 563 
Rabiet, M., Togola, A., Brissaud, F., Seidel, J.L., Budzinski, H., Elbaz-Poulichet, F., 2006. 564 
Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and 565 
groundwaters of a Medium-size Mediterranean catchment. Environ. Sci. Technol. 40, 5282-5288. 566 
http://dx.doi.org/ 10.1021/es060528p. 567 
 568 
Robles-Molina, J., Lara-Ortega, F.J.,  Gilbert-López, B., García-Reyes, J.F., Molina-Díaz, A., 2014. 569 
Multi-residue method for the determination of over 400 priority and emerging pollutants in water 570 
and wastewater by solid-phase extraction and liquid chromatography-time-of-flight mass 571 
spectrometry. Journ of Chromatography. 1350, 30-43. http://dx.doi.org/ 572 
10.1016/j.chroma.2014.05.003  573 
 574 
Sacher, F., Lange, F.T., Brauch, H.J., Blankehorn, I., 2001. Pharmaceuticals in groundwaters-analytical 575 
methods and results of a monitoring program in Baden-Würtenberg, Germany. J. Chromatogr. 576 
A938, 199-210. http://dx.doi.org/10.1016/S0021-9673(01)01266-3. 577 
 578 
Teijón, G., Candela, L., Tamoh, K., Molina-Díaz, A., Fernández-Alba, A.R., 2010. Occurrence of 579 
emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated 580 
wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci. Total Environ. 408, 581 
3584-3595. http://dx.doi.org/ 10.1016/j.scitotenv.2010.04.041. 582 
 583 
Teijón, G., Candela, L., Sagristá, E., Hidalgo, M., 2013. Naproxen adsorption-desorption in a sandy 584 
aquifer matrix-characterisation of hysteretic behaviour at two different temperature values. Soil. 585 
Sedim. Contam. 22(69), 641-653. http://dx.doi.org/10.1080/15320383.2013.756446. 586 
 587 
Ternes, T., Meisenheimer, M., Mcdowell, D., Sacher, F., Brauch, H., Haist-Gulde, B., 2002. Removal 588 
of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36, 3855-3863. 589 
http://dx.doi.org/ 10.1021/es015757k. 590 
 591 
Vogel, J.R., Verstraeten, I.M., Coplen, T.B., Furlong, E.T., Meyer, M.T., Barber, L.B., 2005. 592 
Occurrence of selected pharmaceutical and non-pharmaceutical compounds and stable hydrogen 593 
and oxygen isotope ratios. a Riverbank Filtration Study, Platte River, Nebraska, 2001 to 2003, 594 
Volume 1, Data Series, vol. 117, U.S. Geological Survey, Reston, Virginia 595 
596 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
18 
 
Figures and table captions 597 
 598 
Table 1. Selected pharmaceuticals, CAS number and use analysed in the water sampled. Compounds 599 
detected in at least one water sample.  600 
 601 
Table 2. Pharmaceuticals detected in groundwater (RL1, RL2, RL3 and RL5 wells) and injected water 602 
(TWW) at concentration greater than 0.1 μgl-1, in at least one sample. The minimum, maximum and 603 
mean values considering all wells are also presented for the monitored period. (Due to the absence of 604 
regulated limits for this type of compounds, the concentration of 0.1 μgl-1has been considered as a 605 
threshold value in this study). 606 
 607 
Fig 1.  Study site location and geologic cross-section of the delta aquifer. Injection wells (P1 to P4) and 608 
monitoring wells (RL1, RL2, RL3 and RL5) are also shown. 609 
 610 
Fig. 2. Changes of HCO3
- and SO4= versus Cl- in the monitored wells (RL1, RL2 and RL5) and 611 
sampling campaigns during the study period (2007-2010). 612 
 613 
Fig. 3.  Stiff diagrams for selected monitoring wells: aquifer background (left diagram) and the last 614 
sampling campaign (right diagram). 615 
 616 
Fig.4.  Presence in the aquifer media and TWW of carbamazepine, diclofenac, hydrochlorothiazide and 617 
sulfonamides (sulfamethoxazole , sulfamethazine, sulfapyridine), 4-AAA, 4-FAA and O2, NO3
-, NH4
+ 618 
and Cl- for the study period. The oxidation front from TWW injection is also shown.  619 
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Compound CAS number and use   
4-amino-antipyrine (4-AA)  (d)  83-07-8 Analgesic and anti-inflammatory  
4-dimethylaminoantipyrine (4-DAA) (ND) 58-15-1 Analgesic, anti-inflammatory and antipyretic  
4-MAA  (d) 519-98-2 Metabolite of dipyrone  
Acetaminophen (c) 103-90-2 Analgesic  
Amitriptyline (c) 50-48-6 Antidepressant  
Amoxicilin (ND) 26787-78-0 Antibiotic  
Antipyrine  (b) 60-80-0 Analgesic 
Atenolol  (b) 29122-68-7 Cardioselective beta-adrenergic blocker 
Azithromycin (c) 83905-01-5 Antibiotic 
Bezafibrate  (b) 41859-67-0 Peroxisome proliferator and hypolipidaemic agent 
Caffeine  (b) 58-08-2 Central nervous system stimulant 
Carb,Epoxide  (b) 36507-30-9 Metabolite of carbamazepine 
Carbamazepine  (b) 298-46-4 Anticonvulsant 
Cefotaxime  (b) 63527-52-6 Anti bacterial agent 
Ciprofloxacin  (b) 85721-33-1 Antibiotic 
Citalopram  (b) 59729-33-8 Antidepressant 
Clarithromycin  (b) 81103-11-9 Antibiotic 
Clofibric acid  (b) 882-09-7 Herbicide 
Clomipramine (ND) 303-49-1 Antidepressant  
Clotrimazole (ND) 23593-75-1 Antimycotic activity 
Codeine (d) 76-57-3 Analgesic agent 
Cotinine  (b) 486-56-6 Metabolite  of nicotine 
Cyclophosphamide (ND) 50-18-0 Antineoplastic and immunosuppressive agent 
Diatrizoate (ND) 117-96-4 X-ray contrast medium 
Diazepam  (b) 439-14-5 Anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties 
Diclofenac  (b) 15307-86-5 Anti-inflammatory  
Erythromycin (b) 114-07-8 Antibiotic 
Famotidine (ND) 76824-35-6 Histamine H2-receptor antagonist 
Fenofibrate  (b) 49562-28-9 Antilipemic 
Fenofibric acid  (b) 42017-89-0 Metabolite of fenofibrate 
Fenoprofen (d) 31879-05-7 Anti-inflammatory analgesic and antipyretic 
Fluoxetine (ND) 54910-89-3 Antidepressant  
Furosemide  (b) 54-31-9 Diuretic 
Gemfibrozil  (b) 25812-30-0 Lipid-regulating  
Hydrochlorothiazide  (b) 58-93-5 Diuretic 
Ibuprofen (d) 15687-27-1 Anti-inflammatory agent  
Ifosfamide  (b) 3778-73-2 alkylating agent and an immunosuppressive agent 
Indomethacin  (b) 53-86-1 Anti-inflammatory 
Iopamidol (d) 62883-00-5 Contrast agent  
Iopromide (d) 73334-07-3 Contrast agent 
(b): detected in TWW and groundwater; (c): detected only in TWW; (d): detected only in groundwater; (ND): not detected 
      
Table1
Compound  CAS number and use 
Ketoprofen  (b) 22071-15-4 Anti-inflammatory analgesic and antipyretic 
Ketorolac (d) 74103-06-3 Anti-Inflammatory 
Lansoprazole (ND) 103577-45-3 Anti-Infective, antiulcer agent 
Lincomycin  (b) 154-21-2 Antibiotic 
Loratadine (d) 79794-75-5 Antihistamines 
Mefenamic acid  (b) 61-68-7 Analgesic, anti-inflammatory, and antipyretic 
Mepivacaine  (b) 96-88-8 Local anesthetic 
Methylprednisolone 6-alpha sodium succinate (ND) 2375-03-3 Anti-inflammatory 
Metoprolol  (b) 37350-58-6 Adrenergic beta-1-blocking agent 
Metronidazole  (b) 443-48-1 Antibiotic 
Mevastatin (ND) 73573-88-3 Antibiotic, antifungal 
N-acetyl-4-amino-antipyrine (4AAA)  (b) 83-15-8 Metabolite of metamizol 
Nadolol (ND) 42200-33-9 Cardiovascular disease 
Naproxen  (b) 22204-53-1 Anti-inflammatory agent with analgesic and antipyretic properties 
N-formyl-4-amino-antipyrine (4FAA)  (b) 1672-58-8 Metabolite of metamizol 
Nicotine  (b) 54-555-5 Insecticide, tobacco ingredient 
Norfloxacin  (b) 70458-96-7 Antibacterial 
Ofloxacin  (b) 82419-36-1 Antibacterial 
Omeprazole  (b) 73590-58-6 Inhibitor of gastric acid secretion 
Paraxanthine (d) 611-59-6 Central nervous system stimulant. Metabolite of caffeine 
Paroxetine (ND) 61869-08-7 Serotonin uptake inhibitor, depression treatment 
Phenacetin (ND) 62-44-2 Analgesic 
Pravastatin (d) 81093-37-0 Antilipemic fungal metabolite 
Primidone  (b) 125-33-7 Antiepileptic 
Propanolol hydrochloride  (b) 525-66-6 Sympatholytic 
Propyphenazone  (b) 479-92-5 Anti-Inflammatory 
Ranitidine (c) 66357-35-5 Histamine H2-receptor antagonist 
Salbutamol  (b) 18559-94-9 Beta2-adrenergic agonist used to treat  asthma  
Salicilic acid  (b) 69-72-7 Analgesic, antipyretic 
Simvastatin (ND) 79902-63-9 Rate-limiting enzyme in cholesterol biosynthesis 
Sotalol  (b) 3930-20-9 Adrenergic beta-antagonist 
Sulfadiazine  (b) 68-35-9 Antibiotic 
Sulfamethazine  (b) 57-68-1 Antibacterial 
Sulfamethoxazole  (b) 723-46-6 Antibacterial 
Sulfapyridine  (b) 144-83-2 Antibacterial used to treat  skin diseases 
Sulfathiazole  (b) 72-14-0 Anti-Infective agent 
Tamoxifen (ND) 10540-29-1  Selective estrogen receptor modulator 
Terbutaline (ND) 23031-25-6 Bronchodilator and tocolytic 
Tetracycline (ND) 60-54-8 Antibiotic  
Trimethoprim  (b) 738-70-5 Bacteriostatic antibiotic 
Venlafaxine  (b) 93413-69-5 Antidepressant 
 
  
TWW  (ngl-1) Groundwater (ngl-1) 
Min Max Mean Value Min Max Mean Value 
Atenolol 24 218 104 5 106 47 
Caffeine 10 141 40 4 505 73 
Carbamazepine 10 169 82 3 134 46 
Ciprofloxacin  - 52 - 2 406 126 
Codeine - - - 106 348 227 
Diazepam 7 114 39 1 20 7 
Diclofenac 29 622 182 19 74 49 
Erythromycin 14 80 31 7 428 63 
Furosemide 28 115 77 8 218 87 
Gemfibrozil 7 716 203 12 852 255 
Hydrochlorothiazide 2 301 165 2 228 50 
Ibuprofen - - - - 185 185 
Iopamidol - - - 6 396 157 
Iopromide - - - 462 687 575 
Mepivacaine 1 254 78 1 29 7 
N-acetyl-4-amino-antipiryne (4-AAA) 76 678 299 3 236 111 
Naproxen 37 476 233 103 263 170 
N-formyl-4-amino-antipiryne (4-FAA) 110 478 229 27 162 96 
Nicotine 11 155 37 5 190 50 
Ofloxacin 3 516 220 3 178 43 
Paraxanthine - - - 23 147 79 
Sulfamethazine 2 164 50 62 77 70 
Sulfamethoxazole 28 145 82 4 18 9 
Sulfapyridine 11 69 43 17 29 23 
Velafaxime 82 196 138 2 181 104 
 
Table 2
